[Mitoxantrone monotherapy in metastatic breast cancer--initial results of a prospective randomized study in "low risk" patients].
Schaudig
K
K
Frauenklinik, TU München.
Thomssen
C
C
Jänicke
F
F
Graeff
H
H
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008942:Mitoxantrone / Q000008:administration & dosage* / Q000009:adverse effects; D009362:Neoplasm Metastasis; D011446:Prospective Studies; D011788:Quality of Life; D012307:Risk Factors; D015996:Survival Rate
D008942:Mitoxantrone
Mitoxantron Monotherapie beim metastasierten Mammakarzinom--erste Ergebnisse einer prospektiven randomisierten Studie bei "low risk"-Patientinnen.